Active Ingredient(s): Glycerol Phenylbutyrate
FDA Approved: * February 1, 2013
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Ravicti Overview

Monolaurin, also known as glycerol monolaurate (GML), glyceryl laurate or 1-lauroyl-glycerol, is a monoglyceride. It is the mono-ester formed from glycerol and lauric acid. Its chemical formula is C15H30O4. Contents 1 Uses 2 Occurrence 3 Pharmacology 4 References Uses Monolaurin is most commonly used as a surfactant in cosmetics, such as deodorants. As a food additive it is also used as an emulsifier or preservative. Monolaurin is also taken as a dietary supplement. Occurrence Mo...

Read more Ravicti Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Monolaurin

Recent Ravicti Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Glycerol Phenylbutyrate
  • Liquid: 1.1g/ml, 1.1gm/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Ravicti: (2 results)

Sorted by National Drug Code
  • 75987-050 Ravicti 1.1 g/ml Oral Liquid by Horizon Pharma, Inc.
  • 76325-100 Ravicti 1.1 g/ml Oral Liquid by Hyperion Therapeutics, Inc.

Other drugs which contain Glycerol Phenylbutyrate or a similar ingredient: (2 results)